Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.29% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Sep 30, 2025
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001087294-25-000020General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.26% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-8.73% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
35.39% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
88.08% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-23.70% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.11% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.98% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.24%
- Current
- 0.29%
- Delta
- 0.04%
- Previous
- 7.79%
- Current
- 2.26%
- Delta
- -5.53%
- Previous
- 10.04%
- Current
- -8.73%
- Delta
- -18.77%
- Previous
- 29.74%
- Current
- 35.39%
- Delta
- 5.65%
- Previous
- 81.44%
- Current
- 88.08%
- Delta
- 6.64%
- Previous
- -6.90%
- Current
- -23.70%
- Delta
- -16.80%
- Previous
- 13.55%
- Current
- 15.11%
- Delta
- 1.57%
- Previous
- 0.74%
- Current
- 0.98%
- Delta
- 0.24%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Analogous To · CPIX state analogue 5 →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_INCREASED →Transitioned To · CPIX CASH_GENERATION_DECREASED →Transitioned To · CPIX GROWTH_DECREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_DECREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →Transitioned To · CPIX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.